Diabetes: Blood Sugar Sensors Massively Recalled in France after Several Deaths

HEALTH: Diabetes blood sugar sensors are recalled in France because of a malfunction which reportedly led to the death of seven people.

A broad campaign of blood glucose sensor recall is underway in seventeen countries including France and the United States after the identification of a malfunction which could be linked to seven deaths, the pharmaceutical company Abbott announced to AFP on Wednesday 3rd December 2025.

READ ALSO: Diabetes: a new form worries experts, 25 million people affected worldwide

Seven deaths possibly linked to this malfunction

This operation concerns “certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors” used by diabetic patients, detailed this official in a press release, explaining that “internal tests determined that some of these sensors could provide incorrect measurements of low blood sugar”.

The company said it has received reports to date of seven deaths and 736 serious incidents which could be linked to this malfunction.

Used in the management of diabetes, blood glucose sensors continuously monitor glucose, and thus help patients prevent the risk of hypoglycemia or hyperglycemia which can cause coma or death without treatment.

The defective devices are linked to a single production line, said the company, which alerted the health authorities of the countries in which they were marketed and initiated a recall action.

In the United States alone, around 3 million faulty sensors would have been distributed, estimates the Abbott company.

Other countries affected are Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Luxembourg, the Netherlands, New Zealand, Norway, Germany, Sweden, Switzerland and the United Kingdom.